To assess α3β1 expression among breast cancer samples, we first performed immunohistochemistry on commercially available tissue microarrays (TMAs) using an antiserum specific for the integrin α3 subunit (ITGA3), or the corresponding preimmune serum from the same rabbit as a calibration control [33]. This evidence concerns the gene ITGA3 and breast carcinoma.